Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Gkaliagkousi, E.
Right arrow Articles by Ferro, A.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reviews

Review: Pharmacological and non-pharmacological treatment of endothelial dysfunction: relevance to diabetes

Eugenia Gkaliagkousi

Department of Clinical Pharmacology, Cardiovascular Division, GKT School of Medicine, King's College London, UK

Ashish Shah

Department of Clinical Pharmacology, Cardiovascular Division, GKT School of Medicine, King's College London, UK

Albert Ferro

Department of Clinical Pharmacology, Cardiovascular Division, GKT School of Medicine, King's College London, UK, albert.ferro{at}kcl.ac.uk

Vascular disease is the most important complication of both type 1 and type 2 diabetes, with both micro- and macrovascular disease underlying most of the death and disability observed in diabetic patients. Endothelial dysfunction is a cardinal feature of both types of diabetes, and is believed to be involved in the aetiology and pathophysiology of diabetic vasculopathy. Therefore, measures which improve endothelial dysfunction in diabetes are currently the subject of much interest and research. In this article, we review both drug and non-drug therapies for endothelial dysfunction, along with evidence of their effectiveness in diabetes. We suggest that those therapies for which good evidence of endothelial benefit exists should be more widely used in diabetic patients, and that the maximum benefit will be derived by using multiple such therapies in combination.

Key Words: diabetes • cardiovascular disease • endothelium • non-pharmacological treatment • pharmacological treatment.

References

  • Winer N., Sowers JR Epidemiology of diabetes. J Clin Pharmacol 2004; 44:397-405.[Abstract/Free Full Text]
  • Steinberg HO, Paradisi G., Cronin J. et al. Type II diabetes abrogates sex differences in endothelial function in premenopausal women. Circulation 2000;101:2040-6.[Abstract/Free Full Text]
  • Chan NN, Vallance P., Colhoun HM Endothelium-dependent and -independent vascular dysfunction in type 1 diabetes: role of conventional risk factors, sex, and glycemic control. Arterioscler Thromb Vasc Biol 2003; 23:1048-54.[Abstract/Free Full Text]
  • Clarkson P., Celermajer DS, Donald AE et al. Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. J Am Coll Cardiol 1996;28:573-9.[Abstract]
  • Makimattila S., Virkamaki A., Groop PH et al. Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus. Circulation 1996;94:1276-82.[Abstract/Free Full Text]
  • Williams SB, Cusco JA, Roddy MA et al. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1996;27:567-74.[Abstract]
  • McVeigh GE, Brennan GM, Johnston GD et al. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992;35:771-6.[Web of Science][Medline] [Order article via Infotrieve]
  • Makimattila S., Liu ML, Vakkilainen J. et al. Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants. Diabetes Care 1999;22:973-81.[Abstract]
  • McNeill KL, Fontana L., Russell-Jones DL et al. Inhibitory effects of low-density lipoproteins from men with type II diabetes on endotheliumdependent relaxation. J Am Coll Cardiol 2000;35:1622-7.[Abstract/Free Full Text]
  • Watts GF, O'Brien SF, Silvester W., Millar JA Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: role of dyslipidaemia. Clin Sci (Lond) 1996;91:567-73.[Medline] [Order article via Infotrieve]
  • Jaap AJ, Pym CA, Seamark C. et al. Microvascular function in type 2 (non-insulin-dependent) diabetes: improved vasodilation after one year of good glycaemic control. Diabet Med 1995;12:1086-91.[Web of Science][Medline] [Order article via Infotrieve]
  • Aversano T., Ouyang P., Silverman H. Blockade of the ATP-sensitive potassium channel modulates reactive hyperaemia in the canine coronary circulation. Circ Res 1991;69:618-22.[Abstract/Free Full Text]
  • Sundaresan P., Lykos D., Daher A. et al. Acute effects of oral glibenclamide on blood pressure and forearm vascular resistance in diabetics. Clin Exp Pharmacol Physiol 1997;24:333-5.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Ueba H., Kuroki M., Hashimoto S. et al. Glimepiride induces nitric oxide production in human coronary artery endothelial cells via a PI3-kinase-Akt dependent pathway. Atherosclerosis 2005;183:35-9.[Medline] [Order article via Infotrieve]
  • Arcaro G., Cretti A., Balzano S. et al. Insulin causes endothelial dysfunction in humans: sites and mechanisms. Circulation 2002;105:576-82.[Abstract/Free Full Text]
  • Vehkavaara S., Makimattila S., Schlenzka A. et al. Insulin therapy improves endothelial function in type 2 diabetes. Arterioscler Thromb Vasc Biol 2000;20:545-50.[Abstract/Free Full Text]
  • Caballero AE, Saouaf R., Lim SC et al. The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial. Metabolism 2003;52:173-80.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Tack CJ, Ong MK, Lutterman JA, Smits P. Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone. Diabetologia 1998;41:569-76.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Vitale C., Mercuro G., Cornoldi A. et al. Metformin improves endothelial function in patients with metabolic syndrome. J Intern Med 2005;258: 250-6.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • De JJ, Kooy A., Lehert P. et al. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial. J Intern Med 2005;257:100-09.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Wierzbicki AS, Poston R., Ferro A. The lipid and non-lipid effects of statins. Pharmacol Ther 2003;99:95-112.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Keech A., Simes RJ, Barter P. et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 2005;366:1849-61.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Evans M., Anderson RA, Graham J. et al. Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus. Circulation 2000;101:1773-9.[Abstract/Free Full Text]
  • Fegan PG, Shore AC, Mawson D. et al. Microvascular endothelial function in subjects with Type 2 diabetes and the effect of ( lipid-lowering therapy. Diabet Med 2005;22:1670-6.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Schiffrin EL, Park JB, Pu Q. Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function. J Hypertens 2002;20:71-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • O'Driscoll G., Green D., Rankin J. et al. Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus. J Clin Invest 1997;100:678-84.[Web of Science][Medline] [Order article via Infotrieve]
  • O'Driscoll G., Green D., Maiorana A. et al. Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1999;33:1506-11.[Abstract/Free Full Text]
  • Cheetham C., Collis J., O'Driscoll G. et al. Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes. J Am Coll Cardiol 2000;36:1461-6.[Abstract/Free Full Text]
  • Fuchsjager-Mayrl G., Pleiner J., Wiesinger GF et al. Exercise training improves vascular endothelial function in patients with type 1 diabetes. Diabetes Care 2002;25:1795-801.[Abstract/Free Full Text]
  • Maiorana A., O'Driscoll G., Cheetham C. et al. The effect of combined aerobic and resistance exercise training on vascular function in type 2 diabetes. J Am Coll Cardiol 2001;38:860-6.[Abstract/Free Full Text]
  • Chowienczyk PJ, Brett SE, Gopaul NK et al. Oral treatment with an antioxidant (raxofelast) reduces oxidative stress and improves endothelial function in men with type II diabetes. Diabetologia 2000;43:974-7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Gazis A., White DJ, Page SR, Cockcroft JR Effect of oral vitamin E (alpha-tocopherol) supplementation on vascular endothelial function in Type 2 diabetes mellitus. Diabet Med 1999;16:304-11.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Beckman JA, Goldfine AB, Gordon MB et al. Oral antioxidant therapy improves endothelial function in Type 1 but not Type 2 diabetes mellitus. Am J Physiol Heart Circ Physiol 2003;285:H2392-H2398.[Abstract/Free Full Text]
  • Butler R., Morris AD, Belch JJ et al. Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 2000; 35:746-51.[Abstract/Free Full Text]
  • McVeigh GE, Brennan GM, Cohn JN et al. Fish oil improves arterial compliance in non-insulin-dependent diabetes mellitus. Arterioscler Thromb 1994;14:1425-9.[Abstract/Free Full Text]
  • McVeigh GE, Brennan GM, Johnston GD et al. Dietary fish oil augments nitric oxide production or release in patients with type 2 (non-insulindependent) diabetes mellitus. Diabetologia 1993;36:33-8.[Web of Science][Medline] [Order article via Infotrieve]
  • Kass DA, Shapiro EP, Kawaguchi M. et al. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation 2001;104:1464-70.[Abstract/Free Full Text]
  • Picchi A., Gao X., Belmadani S. et al. Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome. Circ Res 2006;99:69-77.[Abstract/Free Full Text]
  • Martens FM, Rabelink TJ, Op 't RJ, de Koning EJ, Visseren FL TNF-{alpha} induces endothelial dysfunction in diabetic adults, an effect reversible by the PPAR-{gamma} agonist pioglitazone. Eur Heart J 2006;27:1605-09.[Abstract/Free Full Text]
  • Mullen MJ, Wright D., Donald AE, Thorne S., Thomson H., Deanfield JE Atorvastatin but not L-arginine improves endothelial function in type I diabetes mellitus: a double-blind study. J Am Coll Cardiol 2000;36:410-16.[Abstract/Free Full Text]

The British Journal of Diabetes & Vascular Disease, Vol. 7, No. 1, 5-10 (2007)
DOI: 10.1177/14746514070070010201
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Gkaliagkousi, E.
Right arrow Articles by Ferro, A.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?